Real-World Study Shows Effectiveness of Ixekizumab for Psoriasis
Significant clinical improvements seen with and without induction therapy, with faster initial response with induction
Semaglutide May Reduce Craving in Alcohol Use Disorder
Phase 2 trial shows significant reduction in drinks per drinking day and weekly alcohol craving
FDA Makes Access to Clozapine Easier for Patients With Schizophrenia
Patients will no longer have to provide blood test results before filling their prescription
Weight Loss After Antiobesity Medication Initiation Lowers Joint Revision Risk
Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement
Second Flu Vaccine Meeting Canceled — What Happens Next?
2017 to 2022 Saw Rise in ED Orders for Buprenorphine for Opioid Use Disorder
One in nine patients starting with emergency prescription go on to receive continuous buprenorphine prescription within one year
Obinutuzumab Efficacious for Renal Response in Lupus Nephritis
More patients receiving obinutuzumab plus standard therapy versus standard therapy alone had a complete renal response at week 76
One in Six Patients in Phase 2 Cancer Trials Receive Drug When Eventually Approved
Proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit
Advisory Committee on Immunization Practices February Meeting Postponed
President of the American College of Physicians calls for prompt rescheduling of the meeting
Guidance Provided for Safe Use of Ketamine
Ketamine use outside of acute pain management and procedural sedation should be part of comprehensive treatment plan by trained medical professionals
